DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,139,037 | +2.1% | 48,928 | -1.2% | 3.94% | +6.4% |
| Q2 2023 | $11,886,240 | -5.8% | 49,526 | -1.0% | 3.71% | -9.0% |
| Q1 2023 | $12,614,602 | -3.3% | 50,050 | +1.8% | 4.07% | -19.5% |
| Q4 2022 | $13,044,597 | +4.3% | 49,147 | +1.5% | 5.06% | -1.6% |
| Q3 2022 | $12,510,000 | +2.3% | 48,435 | +0.4% | 5.14% | +7.6% |
| Q2 2022 | $12,226,000 | -11.7% | 48,226 | +2.1% | 4.78% | +9.4% |
| Q1 2022 | $13,853,000 | -11.4% | 47,226 | -0.6% | 4.36% | +0.6% |
| Q4 2021 | $15,630,000 | +7.6% | 47,507 | -0.4% | 4.34% | +0.6% |
| Q3 2021 | $14,525,000 | +13.9% | 47,709 | +0.4% | 4.31% | +8.4% |
| Q2 2021 | $12,750,000 | +18.5% | 47,511 | -0.6% | 3.98% | +4.9% |
| Q1 2021 | $10,759,000 | +2.7% | 47,803 | +1.4% | 3.79% | +0.5% |
| Q4 2020 | $10,472,000 | +3.3% | 47,141 | +0.1% | 3.77% | -6.0% |
| Q3 2020 | $10,136,000 | +20.4% | 47,072 | -1.1% | 4.01% | +9.1% |
| Q2 2020 | $8,420,000 | +29.0% | 47,619 | +1.0% | 3.68% | +1.3% |
| Q1 2020 | $6,526,000 | -8.5% | 47,148 | +1.4% | 3.63% | +4.3% |
| Q4 2019 | $7,136,000 | +8.2% | 46,496 | +1.8% | 3.48% | -1.4% |
| Q3 2019 | $6,594,000 | +7.4% | 45,654 | +6.3% | 3.53% | +2.6% |
| Q2 2019 | $6,141,000 | +8.9% | 42,965 | +0.6% | 3.44% | +5.0% |
| Q1 2019 | $5,637,000 | +29.4% | 42,701 | +1.1% | 3.28% | +9.6% |
| Q4 2018 | $4,356,000 | +0.3% | 42,240 | +5.7% | 2.99% | +15.5% |
| Q3 2018 | $4,342,000 | +14.1% | 39,959 | +3.6% | 2.59% | +5.5% |
| Q2 2018 | $3,807,000 | +0.8% | 38,576 | +0.0% | 2.46% | -2.9% |
| Q1 2018 | $3,776,000 | +9.6% | 38,565 | +3.9% | 2.53% | +9.4% |
| Q4 2017 | $3,444,000 | +14.6% | 37,108 | +5.9% | 2.31% | +2.1% |
| Q3 2017 | $3,005,000 | +6.9% | 35,034 | +5.2% | 2.26% | +3.6% |
| Q2 2017 | $2,812,000 | +308.7% | 33,317 | +314.0% | 2.19% | +281.7% |
| Q1 2017 | $688,000 | +11.9% | 8,048 | +1.9% | 0.57% | +1.8% |
| Q4 2016 | $615,000 | – | 7,898 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |